Clinton Foundation Makes Huge HIV/AIDS Buy From India’s Cipla
This article was originally published in PharmAsia News
Executive Summary
The foundation of former U.S. President Bill Clinton has made a large buy of pediatric antiretroviral drugs from India's Cipla. The drugs are to be distributed by the Clinton Foundation in 62 developing countries with most of the children with HIV/AIDS. A Cipla physician said the firm was chosen in part because it is one of only a few companies with a pediatric dosage of the AIDS drug. Of the 22 retrovirals approved by the U.S. FDA, only five are either available in a pediatric dosage or approved for use in children. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.